NJ Joins $26B Opioid Settlement With J&J, Pharma Cos.

By Jeannie O'Sullivan · August 20, 2021, 7:00 PM EDT

New Jersey intends to join a $26 billion settlement with Johnson & Johnson and three pharmaceutical distribution companies in sprawling multidistrict litigation over the companies' roles in the opioid crisis, acting...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re: National Prescription Opiate Litigation

Case Number

1:17-md-02804

Court

Ohio Northern

Nature of Suit

P.I.: Other

Date Filed

November 04, 2022